by rodrickkirtley | Apr 23, 2022 | Non classé
Selpercatinib is the first drug from Loxo’s pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG. Flair also analysed dozens of open letters...